Table I.
Characteristics | STC1 positive, n | STC1 negative, n | P-value |
---|---|---|---|
Total | 89 | 140 | |
Age, yearsa | 62.5 (38–81) | 64.1 (36–85) | 0.709 |
Gender | |||
Male | 78 | 127 | |
Female | 11 | 13 | 0.463 |
Tumor location | |||
Ce/Ut | 12 | 19 | |
Mt/Lt/Ae | 77 | 121 | 0.985 |
T status | |||
pT 0-2 | 24 | 59 | |
pT 3-4 | 65 | 81 | 0.019 |
Number of pN | |||
<4 | 55 | 99 | |
≥4 | 34 | 41 | 0.162 |
ly status | |||
ly0 | 12 | 29 | |
ly1 | 35 | 51 | |
ly2-3 | 42 | 60 | 0.368 |
v status | |||
v0 | 48 | 77 | |
v1 | 24 | 42 | |
v2-3 | 17 | 21 | 0.694 |
pStage | |||
pStage 1-2 | 37 | 66 | |
pStage 3-4 | 52 | 74 | 0.408 |
Neo-adjuvant chemotherapy | |||
Yes | 51 | 62 | |
No | 38 | 78 | 0.329 |
Data are average and (range).
Ce, cervical; Ut, upper thoracic; Mt, middle thoracic; Lt, lower thoracic; Ae, abdominal/esophageal; pT, pN, pStage, pathological classification; number of pN, the number of metastasis-positive lymph nodes; ly, lymphatic invasion; v, venous invasion.